Fycompa Tablet
Product Images NDC 69616-280

Product Visual Gallery

This gallery contains 32 technical images submitted to the FDA as part of the official labeling for Fycompa (NDC 69616-280). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Catalyst Pharmaceuticals, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Image Description (0.5 mg mL Oral Suspension Bottle Label)

Fycompa is an oral suspension medication indicated for certain conditions. It should be stored below 30°C and should not be frozen. The dosage and usage information can be found in the accompanying prescribing information. The bottle should be shaken well before each use and any unused portion should be discarded after 90 days.*

FDA Label Image

Image Description (0.5 mg mL Oral Suspension Carton Label)

FDA Label Image

Image Description (10mg Label 30 Ct Italy)

FDA Label Image

Image Description (10mg Label 30 Ct Japan)

FDA Label Image

Image Description (12mg Label 30 Ct Italy)

FDA Label Image

Image Description (12mg Label 30 Ct Japan)

FDA Label Image

Image Description (2 mg Fycompa Inner Sample Kit)

This text provides instructions for taking a medication called Fycompa (perampanel) tablets. The recommended dosage is one tablet taken orally once daily at bedtime. The text also mentions that the sample kit package contains fourteen tablets, each of 2mg strength. Additionally, it includes storage instructions to keep the tablets at a temperature of 25°C (77°F) with excursions allowed between 15°C-30°C (9°F-86°F). The text advises referring to the accompanying prescribing information for more details.*

FDA Label Image

Image Description (2 mg Sample Kit Japan)

Fycompar is a medication available in tablet form, specifically perampanel tablets with a strength of 2mg. The package contains a 2-week sample kit with fourteen 2mg tablets. It is important for healthcare professionals to warn that Fycompar should be kept out of reach of children. The package also includes an instruction to open the card and push the tablet through from the inside. Additionally, patients are advised to read the accompanying Medication Guide before taking Fycompar.*

FDA Label Image

Image Description (2mg Sample Kit Italy)

FDA Label Image

Image Description (2mg Label 30 Ct Italy)

FDA Label Image

Image Description (2mg Label 30 Ct Japan)

FDA Label Image

Image Description (4mg Label 30 Ct Italy)

FDA Label Image

Image Description (4mg Label 30 Ct Japan)

FDA Label Image

Image Description (6mg Label 30 Ct Italy)

FDA Label Image

Image Description (6mg Label 30 Ct Japan)

FDA Label Image

Image Description (8 mg Label 30 Ct Japan)

FDA Label Image

Image Description (8mg Label 30 Ct Italy)

FDA Label Image

Image Description (Fycompa 01)

FDA Label Image

Image Description (Fycompa 02)

FDA Label Image

Image Description (Fycompa 03)

FDA Label Image

Image Description (Fycompa 04)

This text appears to be a table presenting the proportion of patients in different treatment groups. The treatment groups mentioned are "Placcbo" and "FYCOMPA". The numbers 50, 30, 20, and 10 seem to represent percentages of patients falling into different categories. However, without additional context or a clear structure, it is challenging to determine the exact meaning of these proportions.*

FDA Label Image

Image Description (Fycompa 05)

FDA Label Image

Image Description (Fycompa 06)

FDA Label Image

Image Description (Fycompa 07)

FDA Label Image

Image Description (Fycompa 08)

FDA Label Image

Image Description (Fycompa 09)

FDA Label Image

Image Description (Fycompa 10)

FDA Label Image

Image Description (Fycompa 11)

FDA Label Image

Image Description (Fycompa 12)

FDA Label Image

Image Description (Fycompa 13)

FDA Label Image

Image Description (Fycompa 14)

FDA Label Image

Image Description (Fycompa 15)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.